Placebo to match 5-mg PTC518 tablets, Placebo to match 20-mg PTC518 tablets, PTC518, PTC518
PTC518-CNS-002-HD
Phase 2 small_molecule active
Quick answer
Placebo to match 5-mg PTC518 tablets, Placebo to match 20-mg PTC518 tablets, PTC518, PTC518 for Huntington’s Disease is a Phase 2 program (small_molecule) at PTC THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PTC THERAPEUTICS, INC.
- Indication
- Huntington’s Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active